Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
about
CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive VaccinesInfluenza virus activates inflammasomes via its intracellular M2 ion channelHarnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cellsIn situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in miceA nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malariaImmunization delivered by lentiviral vectors for cancer and infectious diseases.Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.Immunoglobulin Fc fragment tagging allows strong activation of endogenous CD4 T cells to reshape the tumor milieu and enhance the antitumor effect of lentivector immunization.A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responsesPatients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes.Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivectorLentivirus as a potent and mechanistically distinct vector for genetic immunizationRecombinant lentivector as a genetic immunization vehicle for antitumor immunity.Engineering oncolytic measles virus to circumvent the intracellular innate immune response.Novel strategies for improved cancer vaccines.Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.Lentiviral vectors for immunization: an inflammatory field.Fusion to the Lysosome Targeting Signal of the Invariant Chain Alters the Processing and Enhances the Immunogenicity of HIV-1 Reverse TranscriptaseEmerging applications of lentiviral vectors in dendritic cell-based immunotherapy.Targeting lentiviral vectors for cancer immunotherapy.Lentiviral vectors for cancer immunotherapy and clinical applicationsDendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma.Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.A lentiviral vector pseudotype suitable for vaccine development.Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.A lentiviral vector-based therapeutic vaccine encoding Ag85B-Rv3425 potently increases resistance to acute tuberculosis infection in mice.Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome.Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy.Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.
P2860
Q27014949-9E4F1C38-B725-44A4-A10D-C5A98042B714Q28279385-1CF4B066-5656-47D1-B7E5-397446A3019AQ30431135-C7289026-6770-4A4B-B919-61E9F4739452Q33564383-0AE93084-87A1-4D60-834B-8CA7D903640BQ33586992-51A47D71-5232-4D98-8C1E-26FDE141EF9DQ33779750-3D27FAC4-1B30-4EE2-AC3C-FA9BB8575F08Q33877397-71CA039A-C194-46EA-B860-A898F0BAA679Q34263314-853BFC90-2882-4087-B4DE-6E49CEDD17FDQ34330250-D5045D32-2660-48A6-954D-B2586864093AQ34469817-54A3610C-582B-4A2B-939C-D6BBB4FD907FQ34539879-40F344A6-5123-4D08-A233-8F0ED9476B92Q34767725-F7C7E234-9291-444E-AFCA-B7019B7AD5EEQ34801323-7AC51D2A-4DDE-4B64-BAE5-75C0B2A88836Q34958663-A41C0819-4935-418D-87B9-D8C7BFE9B228Q35982675-1B39C662-D251-4AB5-9704-C575941A1E3FQ35990046-952523CE-7AD5-4FDB-8BC5-2764563F5312Q36368544-705CB7CD-3767-4D31-BA79-7B74D25443CEQ36751598-70B63190-86F0-4CD8-80D8-4EFC12017150Q36969195-1602E5FD-91A7-4431-AB65-09B47340370EQ37123441-86CE497C-17E3-40E1-AE5C-C1266B194A5EQ37324179-9C722AB6-5754-406A-A459-DD0368C20219Q37461365-B80DB8E0-2CD4-4323-9061-A9D0AAB6F54EQ37621566-D783E600-058F-49EB-8A00-7AF37F3ADBB2Q37706590-DC8E6BD0-5C0D-44B5-A4AA-D02BD3786EB2Q37722979-BBF43719-4925-4CA0-BE55-A8DF00449237Q37793233-48B7821C-F339-4C00-BECA-3470D16F23E2Q38043924-3C79138B-E68E-4C25-8C39-E4CB5C65F816Q38147100-9CA8E4C2-2AF6-4E93-B5CF-BCFB6D4F6254Q38762699-8175814D-052E-4097-889D-1EA37B72778EQ39270204-87718DD5-2029-4D8E-AD16-ED9F45191E6DQ39511106-A506792C-1B37-4897-923B-8A55ADD943CCQ39577673-F03253B7-A606-44D5-BD90-F035071C4628Q40213297-5BD1427C-5002-40D0-AFF2-4E610C9A2052Q41139635-618EAAC4-4A48-49DA-A05B-B9E1FA82A803Q41148159-DAF2014F-F1E4-44CE-BF37-016164E9DA8AQ41351026-2CA6AB33-D4B3-439A-8EF6-18647638B246Q41913779-94BEDEB4-DEF5-49F9-A9B5-D7773D31F277Q41952315-3D0CA70E-9549-4DBC-BC44-4ECFB9DF1E4BQ42110927-509B62D3-D425-49C2-8DF1-31B3A15FC8EFQ42131361-2EFB521F-3CD4-407D-9017-57238446EFAD
P2860
Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immunization with a lentiviral ...... ses to an ovalbumin transgene.
@en
type
label
Immunization with a lentiviral ...... ses to an ovalbumin transgene.
@en
prefLabel
Immunization with a lentiviral ...... ses to an ovalbumin transgene.
@en
P2093
P1433
P1476
Immunization with a lentiviral ...... nses to an ovalbumin transgene
@en
P2093
Isabelle Barde
Luciene Lopes
Martin Zenke
Mary K Collins
Ranbir Bailey
Yasuhiro Ikeda
P304
P356
10.1016/J.YMTHE.2005.08.025
P577
2005-11-04T00:00:00Z